Roswell Park Team Provides First Direct Evidence of CD28 Effects on CAR T-Cell Therapy
February 02, 2026
February 02, 2026
BUFFALO, New York, Feb. 2 [Category: BizHospital] -- The Roswell Park Comprehensive Cancer Center posted the following news release:
* * *
Roswell Park Team Provides First Direct Evidence of CD28 Effects on CAR T-Cell Therapy
*
BUFFALO, N.Y. - While chimeric antigen receptor (CAR) T-cell therapy, an emerging form of immunotherapy, has significantly improved survival rates for patients with multiple myeloma, 30-60% of people with this cancer wil . . .
* * *
Roswell Park Team Provides First Direct Evidence of CD28 Effects on CAR T-Cell Therapy
*
BUFFALO, N.Y. - While chimeric antigen receptor (CAR) T-cell therapy, an emerging form of immunotherapy, has significantly improved survival rates for patients with multiple myeloma, 30-60% of people with this cancer wil . . .